Masimo Founder Joe Kiani On The Healthtech Company’s $10 Billion Acquisition

In this week’s edition of InnovationRx, we look at Jennifer Doudna’s $1 billion plan to bring Crispr gene editing to the real world, using “boring” AI in clinics and more.

Continue Reading

News Source: www.forbes.com